
Search
Filter Results
Displaying 131–140 of 909 results
-
Jan 3, 2023
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
The company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
-
Dec 16, 2022
Eye on the Cure Podcast – Episode 37: Rando Allikmets, PhD
December 16, 2022. Rando Allikmets, PhD, talks to host Ben Shaberman.
-
Dec 12, 2022
Resourceful Advocate for Research
Manorthia was diagnosed with retinitis pigmentosa (RP) when she was 22 years old but didn’t start experiencing considerable vision loss until years later. Once she began to notice her vision deteriorating more rapidly, she reached out to the Foundation Fighting Blindness to get involved with the blindness community.
-
Hello my name is Josephine Ortega , I am a college student continuing her passion of art despite me being visually impaired. I was diagnosed with Stargardt disease when I was a child. A rare genetic eye disease that loses the central vision overtime as a child to adulthood.
-
Dec 2, 2022
SparingVision Receives Authorization to Launch US Clinical Trial for its Cone-Preserving Treatment
The emerging therapy is designed to work independent of the mutated gene causing retinitis pigmentosa
-
As part of the Raising Our Sights DIY fundraising program, the Vision Warriors Endurance Program is committed to taking on the challenge of ending vision loss and pushing beyond our limits through fun, active and challenging activities to support the Foundation Fighting Blindness mission.
-
Dec 2, 2022
Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
The LCA5 gene therapy will be the first emerging Opus treatment to move into a human study
-
Dec 2, 2022
Your Dollar Makes a Difference
At the Foundation Fighting Blindness, a dollar is more than just a dollar – it’s a path to transforming lives. But just where does your donation go?
-
Dec 2, 2022
Eye on the Cure Podcast – Episode 36: Sue Bramhall
December 2, 2022. Host Ben Shaberman interviews Sue Bramhall.